PUMA BIOTECHNOLOGY, INC. (PBYI) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 38 days, typically, give or take 9 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Thu, Feb 26, 2026after close 57 8-K
Q3 FY2025Thu, Nov 6, 2025after close 37 8-K
Q2 FY2025Thu, Aug 7, 2025after close 38 8-K
Q1 FY2025Thu, May 8, 2025after close 38 8-K
Q4 FY2024Thu, Feb 27, 2025after close 58 8-K

What they guided beta

Q3 FY2026 "- Raising 2026 net income guidance" exhibit
Q3 FY2026 "“Third quarter U.S. NERLYNX sales were positively impacted by increased year-over-year demand and were negatively impacted by higher than expected gross to net due to an increase in Medicaid and 340B sales, as well as a delay in sales to Puma’s ex-U.S. commercial partners that shifted from the third quarter to the fourth quarter,” said Alan H." exhibit
Q3 FY2026 "Auerbach added, “We anticipate the following key milestones over the next 12 months: (i) presentation of updated data from ALISCA ® -Breast1, a Phase II trial of alisertib in combination with endocrine treatment in patients with chemotherapy-naïve HER2-negative, hormone receptor-positive metastatic breast cancer (San Antonio Breast Cancer Symposium, December 2026); (ii) initiation of discussions with global regulatory agencies regarding the Phase III trial design for alisertib in combination with endocrine treatment in patients with chemotherapy-naïve HER2-negative, hormone receptor-positive m" exhibit
Q3 FY2026 "The $3.5 million year-over-year increase in other income for the first nine months of 2026 resulted primarily from a decrease in interest expense, reflecting a lower debt balance, as Puma paid down its debt principal in May 2026, partially offset by the termination of subleases as of March 31, 2026 and unfavorable exchange rates on Euro-denominated transactions." exhibit
Q3 FY2026 "Fourth Quarter and Full Year 2026 Financial Outlook" exhibit
Q2 FY2026 "Raising 2026 Revenue and Net Income Guidance Based on" exhibit
Q2 FY2026 "Auerbach added, “We anticipate the following key milestones over the next 12 months: (i) initiation of enrollment in ALISCA ® -Lung2, a Phase I/II trial of alisertib in combination with paclitaxel for the treatment of patients with extensive stage small cell lung cancer (Q3 2026); (ii) expansion of enrollment in ALISCA ® -Breast1, a Phase II trial of alisertib in combination with endocrine treatment in patients with chemotherapy-naïve HER2-negative, hormone receptor-positive metastatic breast cancer (H2 2026); (iii) expansion of ALISCA ® -Lung1, a Phase II clinical trial of alisertib monothera" exhibit
Q2 FY2026 "The $2.2 million year-over-year increase in other income for the first six months of 2026 resulted primarily from a decrease in interest expense, which reflects a lower debt balance as we paid down our debt principal in the three months ended June 30, 2026." exhibit
Q2 FY2026 "Third Quarter and Full Year 2026 Financial Outlook" exhibit
Q2 FY2026 "Puma Biotechnology will host a conference call to report its second quarter 2026 financial results and provide an update on its business and outlook at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, August 6, 2026 ." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/PBYI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/PBYI

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

PBYI earnings date badge

HTML

<a href="https://veritasdata.dev/company/PBYI/"><img src="https://veritasdata.dev/embed/PBYI.svg" alt="PBYI earnings date" width="240" height="56"></a>

Markdown

[![PBYI earnings date](https://veritasdata.dev/embed/PBYI.svg)](https://veritasdata.dev/company/PBYI/)

Script

<script async src="https://veritasdata.dev/embed/PBYI.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/PBYI"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.